Logo

MWG Signs Co-Marketing Deal with Genedata

Jun 11, 2004

NEW YORK, June 11 (GenomeWeb News) - MWG Biotech of Ebersberg, Germany, announced today that it has signed a co-marketing agreement with Genedata to provide analysis capabilities for MWG's sequencing, gene array and siRNA services.

 

Under the terms of the deal, the companies will offer the integration of MWG's Genomic Information services with Genedata's Phylosopher platform. Phylosopher will integrate the data that MWG produces with other types of data and will analyze it using Genedata's algorithms.

 

Financial details of the agreement were not provided.

 

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.